http://archive.fast-edgar.com/20260715/AT22JG2FZ22RVZZA22292ZYSBEPC4Z22Z282
Filed on: July 15, 2026
The information in this preliminary pricing supplement is not complete and may be changed. This preliminary pricing supplement and the accompanying prospectus, prospectus supplement and underlying supplement do not constitute an offer to sell these securities, and we are not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.
Filed Pursuant to Rule 424(b)(2)
Registration No. 333-287303
Subject to Completion. Dated... (continue reading...)
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
... (continue reading...)
Filed Pursuant to Rule 424(b)(2)
Registration Statement No. 333-284538
The information in this preliminary pricing supplement is not complete and may be changed. This preliminary pricing supplement is not an offer to sell nor does it seek an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.
Subject to Completion. Dated July 15, 2026.
... (continue reading...)More SEC Filings
View Older Stories-
Form DEFA14A NIKE, Inc.
-
Form 4 Covista Inc. For: Jul 13 Filed by: Beard, Stephen W.
-
Form 13F-HR Vertex Investment Soluti For: Jun 30
-
Form 3 INFINITY NATURAL RESOURC For: Jul 13 Filed by: Dugan Timothy C
-
Form 425 Alternative Credit Incom Filed by: Alternative Credit Income Fund
-
Form 4 BLACKBERRY Ltd For: Jul 14 Filed by: Kurtz Philip S.
-
Form D Celero Capital Fund II
-
Form D Coatue Growth Fund VI
-
Form 6-K VS MEDIA Holdings Ltd For: Jul 15
-
Form DEF 14A NIKE, Inc. For: May 31
-
Form 424B2 BARCLAYS BANK PLC
-
Form 144 MoonLake Immunotherapeut Filed by: Reich Kristian
-
Form 424B3 ROBO.AI INC.
-
Form 8-K Aldeyra Therapeutics, For: Jul 14
-
Form 10-Q Digital Brand Media & For: May 31
-
Form 10-Q CDT Equity Inc. For: Mar 31
-
Form D/A Else Nutrition Holdings
-
Form SCHEDULE 13G/A DEFSEC Technologies Inc. Filed by: Lind Global Fund III LP
-
Form S-1/A Encore Medical, Inc.
-
Form 8-K/A Enova International, For: Jul 10
-
Form D Coatue Growth Fund VI
-
Form 6-K Scorpio Gold Corp For: Jul 15
-
Form 6-K Mako Mining Corp. For: Jul 15
-
Form FWP Morgan Stanley Finance Filed by: Morgan Stanley Finance LLC
-
Form FWP MORGAN STANLEY Filed by: MORGAN STANLEY
-
Form D/A Averill Fund, Ltd.
-
Form 13F-HR CLIFTONLARSONALLEN WEALT For: Jun 30
-
Form 144 MapLight Therapeutics, Filed by: Foff Erin Pennock
-
Form SCHEDULE 13G DEFSEC Technologies Inc. Filed by: Lind Global Fund III LP
-
Form D/A FISYN FUND II LLC
-
Form D BV Houston Heights Land
-
Form 8-K INFINITY NATURAL RESOURC For: Jul 13
-
Form 3 Penguin Solutions, Inc. For: Jul 09 Filed by: Johnson Aaron Michael
-
Form 6-K TRX GOLD Corp For: Jul 15
-
Form 144 Planet Labs PBC Filed by: Robinson Kristen
-
Form 10-K NIKE, Inc. For: May 31
-
Form FWP Morgan Stanley Finance Filed by: Morgan Stanley Finance LLC
-
Form 425 Evernorth Holdings Inc. Filed by: Evernorth Holdings Inc.
-
Form 144 Palantir Technologies Filed by: Moore Alexander D.
-
Form FWP MORGAN STANLEY Filed by: MORGAN STANLEY
-
Form SC TO-I/A FlowStone Opportunity Filed by: FlowStone Opportunity Fund
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 424B2 CITIGROUP INC
-
Form NT 10-Q Eagle Nuclear Energy For: May 31
-
Form D QB1 Partners, LP
-
Form 424B2 UBS AG
-
Form 424B2 BANK OF MONTREAL /CAN/
-
Form 424B2 UBS AG
-
Form FWP Bridgecrest Lending Auto Filed by: Bridgecrest Lending Auto Securitization Trust 2026-3
-
Form 424B2 UBS AG

